Figures & data
Table 1 Demographics of the participants (n = 346)
Table 2 Knowledge of HCPs about adverse drug reaction reporting
Table 3 Types of ADRs to be reported
Fig. 2 a Types of ADRs to be reported (by physicians). b Types of ADRs to be reported (by pharmacists). c Types of ADRs to be reported (by nurses)
![Fig. 2 a Types of ADRs to be reported (by physicians). b Types of ADRs to be reported (by pharmacists). c Types of ADRs to be reported (by nurses)](/cms/asset/1ad12d3f-7bf1-4e45-9628-b20dc2ce9a6b/jppp_a_12315205_f0002.png)
Table 4 Knowledge about pharmacovigilance
Table 5 Attitudes related to ADR reporting
Table 6 Practices related to ADR reporting
Fig. 5 a Practices of ADR reporting (by physicians). b Practices of ADR reporting (by pharmacists). c Practices of ADR reporting (by nurses)
![Fig. 5 a Practices of ADR reporting (by physicians). b Practices of ADR reporting (by pharmacists). c Practices of ADR reporting (by nurses)](/cms/asset/97ee1ea1-5005-49fc-952c-65df5695975d/jppp_a_12315205_f0005.png)
Table 7 Practices related to the modes of ADR reporting
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.